Furthermore, according to the Kaplan-Meier survival analysis conducted with the database (GSE16476, GSE62564, TARGET), neuroblastoma patients with higher expression of DANCR featured a significantly poorer overall survival rate than patients with lower DANCR expression (Figure 1C, P < 0.001). This evidence concerns the gene DANCR and neuroblastoma.